Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

RxSight (RXST) Shares Outstanding (Weighted Average) (2020 - 2025)

Historic Shares Outstanding (Weighted Average) for RxSight (RXST) over the last 6 years, with Q3 2025 value amounting to $41.0 million.

  • RxSight's Shares Outstanding (Weighted Average) rose 295.71% to $41.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $41.0 million, marking a year-over-year increase of 295.71%. This contributed to the annual value of $38.9 million for FY2024, which is 1280.69% up from last year.
  • According to the latest figures from Q3 2025, RxSight's Shares Outstanding (Weighted Average) is $41.0 million, which was up 295.71% from $40.7 million recorded in Q2 2025.
  • In the past 5 years, RxSight's Shares Outstanding (Weighted Average) ranged from a high of $41.0 million in Q3 2025 and a low of $4.0 million during Q1 2021
  • For the 5-year period, RxSight's Shares Outstanding (Weighted Average) averaged around $29.6 million, with its median value being $34.5 million (2023).
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first soared by 58629.69% in 2022, then soared by 295.71% in 2025.
  • RxSight's Shares Outstanding (Weighted Average) (Quarter) stood at $13.6 million in 2021, then skyrocketed by 103.02% to $27.7 million in 2022, then increased by 24.56% to $34.5 million in 2023, then grew by 12.81% to $38.9 million in 2024, then increased by 5.4% to $41.0 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $41.0 million in Q3 2025, compared to $40.7 million in Q2 2025 and $40.5 million in Q1 2025.